CSH Asia: Stem cell, Aging and Rejuvenation

CONFERENCE 2025-09-15 00:00:00-2025-09-19 00:00:00 Suzhou, China 15 &#x2013 19 September 2025 View Conference Website 0

PAPER Strijkert F, Scheenen ME, Huitema RB, van den Berg E, van Munster BC, Spikman JM

Comment on: "Neuropsychiatric Presentations of Common Dementia Syndromes: A Concise Review for Primary Care Team Members".

J Am Geriatr Soc. 2025 Mar 7; Epub 2025 Mar 7 PubMed.

PAPER Bell Z, O'Connor MK, Moo LR

Reply to: Comment on: Neuropsychiatric Presentations of Common Dementia Syndromes: A Concise Review for Primary Care Team Members.

J Am Geriatr Soc. 2025 Mar 7; Epub 2025 Mar 7 PubMed.

PAPER Liu H, Zhang X, Liu Q

A review of AI-based radiogenomics in neurodegenerative disease.

Front Big Data. 2025;8:1515341. Epub 2025 Feb 20 PubMed.

PAPER Besin V, Humardani FM

Early detection of Alzheimer's disease using the MEMORIES mnemonic.

Chronic Dis Transl Med. 2025 Mar;11(1):22-32. Epub 2024 Sep 3 PubMed.

PAPER Martinez JE, Perales-Puchalt J, Rodriguez MJ, Rosselli M, Salazar C, Marquez DX, Lamar M, Vila-Castelar C, Rascovsky K, O'Bryant S, Vintimilla R, Díaz-Santos M, Velez-Uribe I, Quiroz YT, Llibre-Guerra J, US Consortium of Aging, Dementia, Latino Studies (CADLAS)

Discussing the interplay of social determinants of health, aging and Alzheimer's biomarkers in U.S. Latinos.

J Gerontol A Biol Sci Med Sci. 2025 Mar 7; Epub 2025 Mar 7 PubMed.

PAPER Olofsson HE, Englund E

Increased frontocortical microvascular raspberry density in frontotemporal lobar degeneration compared to Lewy body disease and control cases: a neuropathological study.

Free Neuropathol. 2025 Jan;6:7. Epub 2025 Mar 4 PubMed.

PAPER Gonzalez MC, Oftedal L, Lange J, Tovar-Rios DA, Tysnes OB, Paquet C, Marquié M, Boada M, Alcolea D, Rejdak K, Papuc E, Hort J, Falup-Pecurariu C, Aarsland D, Alves G, Maple-Grødem J

Relationship of cognitive decline with glucocerebrosidase activity and amyloid-beta 42 in DLB and PD.

Ann Clin Transl Neurol. 2025 Mar 6; Epub 2025 Mar 6 PubMed.

PAPER Ma J, Tian Y, Du C, Zhu Y, Huang W, Ding C, Wei P, Yi X, Lin Z, Fang W

Cerium-doped Prussian blue biomimetic nanozyme as an amplified pyroptosis inhibitor mitigate Aβ oligomer-induced neurotoxicity in Alzheimer's disease.

J Nanobiotechnology. 2025 Mar 6;23(1):181. PubMed.

PAPER Chen HJ, Zhang M, Wei M, Yu X, Wang Y, Yang J, Li R, Zhao W, Wang X, Zhang S, Wang K, Bai T, Huo Y, Huang W, Dai Z, Ma G, Han Y, Chen G, Shu N

Amyloid pathology related to aberrant structure-function coupling of brain networks in Alzheimer's disease: insights from [18F]-florbetapir PET imaging.

Eur J Nucl Med Mol Imaging. 2025 Mar 7; Epub 2025 Mar 7 PubMed.

PAPER Rosal AE, Martin SL, Strafella AP

The role of Apolipoprotein E4 on cognitive impairment in Parkinson's disease and Parkinsonisms.

Front Neurosci. 2025;19:1515374. Epub 2025 Feb 20 PubMed.

PAPER Tasnády KR, Jehoul R, de Ravé MG, Gijbels MJ, Brône B, Dewachter I, Melotte V, Boesmans W

Gastrointestinal Dysfunction and Low-Grade Inflammation Associate With Enteric Neuronal Amyloid-β in a Model for Amyloid Pathology.

Neurogastroenterol Motil. 2025 Mar 6;:e15016. Epub 2025 Mar 6 PubMed.

PAPER Nie Y, Szebényi K, Wenger LM, Lakatos A, Chinnery PF

Origin and cell type specificity of mitochondrial DNA mutations in C9ORF72 ALS-FTLD human brain organoids.

Sci Adv. 2025 Mar 7;11(10):eadr0690. Epub 2025 Mar 7 PubMed.

PAPER Bobbins A, Davies M, Lynn E, Roy D, Yeomans A, Shakir SA

Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective.

Br J Clin Pharmacol. 2025 Mar 6; Epub 2025 Mar 6 PubMed.

PAPER Ng SI, Xu L, Mueller KD, Liss J, Berisha V

Segmental and Suprasegmental Speech Foundation Models for Classifying Cognitive Risk Factors: Evaluating Out-of-the-Box Performance.

Interspeech. 2024 Sep;2024:917-921. PubMed.